EI
HSTO

EAM Investors’s Histogen Inc. Common Stock HSTO Stock Holding History

EAM Investors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-314
Closed -$345K – 371
2017
Q3 		$345K Hold
314
– – 0.05% 290
2017
Q2 		$361K Buy
+314
New +$382K 0.06% 291

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

EAM Investors's HSTO Position: Q4 2017 in Review

EAM Investors sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 314 shares — an estimated $345K sold.

EAM Investors first reported a position in HSTO in Q2 2017 and held it in 2 quarters. The position peaked at $361K in Q2 2017. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

  • EAM Investors reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • EAM Investors sold 314 Histogen Inc. Common Stock shares in Q4 2017, an estimated $345K.
  • EAM Investors first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 2 quarters.
  • EAM Investors's Histogen Inc. Common Stock position peaked at $361K in Q2 2017.
  • 70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on EAM Investors's 13F filing for Q4 2017, filed 12 Feb 2018.